Insider sale
MONOPAR THERAPEUTICS
$1.17M
33.33K shares
What this filing means
TACTIC PHARMA LLC plans to sell 33.33K shares of MONOPAR THERAPEUTICS valued at approximately $1.17M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 4/2/2025ACC: 0001971857-25-000166
33.33K
Shares to sell
$1.17M
Approx. market value
33.33K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Private Placement
Cash
3/27/2017
33.33KTotal acquired33.33K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/27/2017 | Private Placement Cash | 33.33K | — |
| Total | 33.33K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
33.33K
Market value
$1.17M
4/2/2025
Total
Units
33.33K
Value
$1.17M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
4/2/2025 | 33.33K | $1.17M | NASDAQ | Planned |
| Total | 33.33K | $1.17M | ||